Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Gross Profit (2018 - 2025)

Historic Gross Profit for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $14.0 million.

  • Bio's Gross Profit rose 864.05% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.8 million, marking a year-over-year increase of 1048.39%. This contributed to the annual value of $46.5 million for FY2024, which is 1589.55% up from last year.
  • Per Bio's latest filing, its Gross Profit stood at $14.0 million for Q3 2025, which was up 864.05% from $14.1 million recorded in Q2 2025.
  • Bio's Gross Profit's 5-year high stood at $14.1 million during Q2 2025, with a 5-year trough of $3.5 million in Q1 2021.
  • For the 5-year period, Bio's Gross Profit averaged around $9.1 million, with its median value being $10.2 million (2023).
  • In the last 5 years, Bio's Gross Profit surged by 14398.08% in 2021 and then plummeted by 346.7% in 2024.
  • Bio's Gross Profit (Quarter) stood at $5.7 million in 2021, then skyrocketed by 44.48% to $8.2 million in 2022, then soared by 42.17% to $11.6 million in 2023, then decreased by 3.47% to $11.2 million in 2024, then increased by 24.49% to $14.0 million in 2025.
  • Its last three reported values are $14.0 million in Q3 2025, $14.1 million for Q2 2025, and $12.5 million during Q1 2025.